BiotechTube
Home/Frezent Biological Solutions/Lina Freage-Kahn, PhD
LF

Lina Freage-Kahn, PhD

Chief Scientific Officer, Co-founder

Frezent Biological Solutions

Therapeutic Areas

Oncology

Frezent Biological Solutions Pipeline

DrugIndicationPhase
Undisclosed Antibody/ADC ProgramHead and Neck CancerPre-clinical
Platform PipelineOsteosarcoma, Pancreatic CancerResearch/Discovery

Leadership Team at Frezent Biological Solutions

NS
Natasha Shtraizent, PhD
Chief Executive Officer, Co-founder
View full Frezent Biological Solutions profile